Unreasonable inventors are combining cutting edge scientific discoveries with the world's biggest challenges to build the next generation of global companies. These are the companies we create and invest in at Main Sequence.
Deep tech inventors need more. We have custom built Main Sequence to be ready to help you solve some of the world's greatest challenges with science.
We are hands-on and have built a services offering to support founders alongside our capital.
Main Sequence was founded by CSIRO in 2017 to address the ‘valley of death’ between research and commercialisation.
Main Sequence’s origins within CSIRO reflect its commitment to amplifying connections between industry, research and infrastructure to accelerate deep technology development, and reinvesting economic returns from commercialisation back into science.
CSIRO Innovation Funds 1 and 2 managed by Main Sequence, have invested in 51 companies since establishment in 2017. These companies have created over 2100 jobs by working with partners in industry, CSIRO, and 28 Australian universities.
The $240 million first CSIRO Innovation Fund, built on a cornerstone investment by government and CSIRO has completed its portfolio and invested in 27 companies since establishment in 2017.
The second $300 million CSIRO Innovation Fund commenced investing mid-2021 and has invested in 24 companies.
During 2023 Fund 3 has raised $450 million, surpassing $1 billion in total funds under management and making its first five Fund 3 investments.
We collaborate with a global community of co-investors who work with us to help our companies scale.
We love companies that solve one or more of these challenge areas. Explore each one below and get to know some of the companies we have already backed.
